David W. Piotrowski

3.1k total citations
65 papers, 1.9k citations indexed

About

David W. Piotrowski is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David W. Piotrowski has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Organic Chemistry and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David W. Piotrowski's work include Chemical Synthesis and Analysis (17 papers), Asymmetric Synthesis and Catalysis (9 papers) and Historical Linguistics and Language Studies (7 papers). David W. Piotrowski is often cited by papers focused on Chemical Synthesis and Analysis (17 papers), Asymmetric Synthesis and Catalysis (9 papers) and Historical Linguistics and Language Studies (7 papers). David W. Piotrowski collaborates with scholars based in United States, China and Italy. David W. Piotrowski's co-authors include Theodor Weber, Scott E. Denmark, Allyn T. Londregan, Jun Xiao, Nicole R. Higdon, Roch Ogier, Daniel Bertrand, Judy A. Lawson, Sonia Bertrand and M. Raggenbass and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Neuroscience.

In The Last Decade

David W. Piotrowski

63 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Piotrowski United States 24 1.0k 865 205 152 142 65 1.9k
Naoki Toyooka Japan 27 906 0.9× 1.4k 1.6× 108 0.5× 60 0.4× 286 2.0× 186 2.5k
David S. Garvey United States 26 935 0.9× 1.2k 1.4× 123 0.6× 49 0.3× 504 3.5× 54 2.2k
Jordi Bujons Spain 26 1.1k 1.1× 829 1.0× 130 0.6× 45 0.3× 84 0.6× 84 1.8k
Jana Sopková‐de Oliveira Santos France 24 845 0.8× 982 1.1× 116 0.6× 36 0.2× 422 3.0× 122 2.1k
Robert M. DiPardo United States 21 1.5k 1.4× 1.4k 1.6× 680 3.3× 80 0.5× 260 1.8× 57 2.7k
David A. Griffith United States 22 1.2k 1.2× 880 1.0× 247 1.2× 236 1.6× 249 1.8× 52 2.5k
Kenneth E. Rittle United States 20 1.3k 1.3× 1.3k 1.5× 585 2.9× 75 0.5× 278 2.0× 38 2.5k
Andrew D. White United States 18 1.1k 1.1× 666 0.8× 260 1.3× 43 0.3× 166 1.2× 37 2.0k
Paul C. Trippier United States 21 802 0.8× 827 1.0× 123 0.6× 58 0.4× 224 1.6× 55 1.8k
Michael D. Ennis United States 19 702 0.7× 1.5k 1.7× 74 0.4× 74 0.5× 238 1.7× 37 2.1k

Countries citing papers authored by David W. Piotrowski

Since Specialization
Citations

This map shows the geographic impact of David W. Piotrowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Piotrowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Piotrowski more than expected).

Fields of papers citing papers by David W. Piotrowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Piotrowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Piotrowski. The network helps show where David W. Piotrowski may publish in the future.

Co-authorship network of co-authors of David W. Piotrowski

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Piotrowski. A scholar is included among the top collaborators of David W. Piotrowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Piotrowski. David W. Piotrowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aspnes, Gary E., Steven B. Coffey, Anne‐Marie Dechert‐Schmitt, et al.. (2023). Small molecule inhibitors of PCSK9. SAR investigations of head and amine groups. Bioorganic & Medicinal Chemistry Letters. 92. 129394–129394. 1 indexed citations
2.
Aspnes, Gary E., Scott W. Bagley, Steven B. Coffey, et al.. (2023). 6-Azaspiro[2.5]octanes as small molecule agonists of the human glucagon-like peptide-1 receptor. Bioorganic & Medicinal Chemistry Letters. 94. 129454–129454. 4 indexed citations
3.
Baldwin, Aaron F., Shawn Cabral, Jeffrey T. Kohrt, et al.. (2023). Route Optimization of the Non-covalent Modulator of Hemoglobin PF-07059013 for the Treatment of Sickle Cell Disease, Part I: From Discovery Synthesis to First Kilogram-Scale Manufacture. Organic Process Research & Development. 27(5). 854–865. 2 indexed citations
4.
Ahmad, Omar, et al.. (2021). Acylative Dynamic Kinetic Resolution of Secondary Alcohols: Tandem Catalysis by HyperBTM and Bäckvall’s Ruthenium Complex. The Journal of Organic Chemistry. 86(10). 7189–7202. 11 indexed citations
5.
Flood, Dillon T., Xue‐Jing Zhang, Xiang Fu, et al.. (2020). RASS‐Enabled S/P−C and S−N Bond Formation for DEL Synthesis. Angewandte Chemie. 132(19). 7447–7453. 9 indexed citations
6.
Flood, Dillon T., Xue‐Jing Zhang, Xiang Fu, et al.. (2020). RASS‐Enabled S/P−C and S−N Bond Formation for DEL Synthesis. Angewandte Chemie International Edition. 59(19). 7377–7383. 54 indexed citations
7.
Flood, Dillon T., Shota Asai, Xue‐Jing Zhang, et al.. (2019). Expanding Reactivity in DNA-Encoded Library Synthesis via Reversible Binding of DNA to an Inert Quaternary Ammonium Support. Journal of the American Chemical Society. 141(25). 9998–10006. 130 indexed citations
8.
Londregan, Allyn T., Gary E. Aspnes, Chris Limberakis, et al.. (2018). Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9. Bioorganic & Medicinal Chemistry Letters. 28(23-24). 3685–3688. 10 indexed citations
9.
Piotrowski, David W., Kentaro Futatsugi, M. F. Sammons, et al.. (2018). David W. Piotrowski, * Kentaro Futatsugi, Agustin Casimiro-Garcia, Liuqing Wei, Matthew F. Sammons, Michael Herr, Wenhua Jiao, Sophie Y. Lavergne, Steven B. Co ff ey, Stephen W. Wright, Kun Song, Paula M. Loria, Mary Ellen Banker, Donna N. Petersen, and J. Journal of Medicinal Chemistry. 3 indexed citations
10.
Lintner, Nathanael G., Kim F. McClure, Donna N. Petersen, et al.. (2017). Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. PLoS Biology. 15(3). e2001882–e2001882. 94 indexed citations
11.
Piotrowski, David W., et al.. (2016). Phénoménologie et linguistique : un entrelacs [Phenomenology and Linguistics: An Interlacing]. 4(2). 1 indexed citations
12.
Visetti, Yves-Marie & David W. Piotrowski. (2015). Expression diacritique et sémiogenèse. 3(1). 63–112. 1 indexed citations
13.
Shao, Qian, Jiean Chen, Meihua Tu, David W. Piotrowski, & Yong Huang. (2013). Enantioselective synthesis of 1,2,4-triazolines catalyzed by a cinchona alkaloid-derived organocatalyst. Chemical Communications. 49(94). 11098–11098. 21 indexed citations
14.
Sharma, Raman, Hao Sun, David W. Piotrowski, et al.. (2012). Metabolism, Excretion, and Pharmacokinetics of ((3,3-Difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, a Dipeptidyl Peptidase Inhibitor, in Rat, Dog and Human. Drug Metabolism and Disposition. 40(11). 2143–2161. 24 indexed citations
15.
Andrews, Kim, David A. Beebe, John W. Benbow, et al.. (2011). 1-((3S,4S)-4-Amino-1-(4-substituted-1,3,5-triazin-2-yl) pyrrolidin-3-yl)-5,5-difluoropiperidin-2-one inhibitors of DPP-4 for the treatment of type 2 diabetes. Bioorganic & Medicinal Chemistry Letters. 21(6). 1810–1814. 16 indexed citations
16.
Piotrowski, David W.. (2009). Phénoménalité et objectivité linguistiques. Honoré Champion eBooks. 1 indexed citations
17.
Humphries, Paul S., John W. Benbow, Paul D. Bonin, et al.. (2009). Synthesis and SAR of 1,2,3,4-tetrahydroisoquinolin-1-ones as novel G-protein-coupled receptor 40 (GPR40) antagonists. Bioorganic & Medicinal Chemistry Letters. 19(9). 2400–2403. 47 indexed citations
18.
Ammirati, Mark, Kim Andrews, Dennis E. Danley, et al.. (2009). (3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: A potent, selective, orally active dipeptidyl peptidase IV inhibitor. Bioorganic & Medicinal Chemistry Letters. 19(7). 1991–1995. 33 indexed citations
19.
Hurst, Raymond S, Mihály Hajós, M. Raggenbass, et al.. (2005). A Novel Positive Allosteric Modulator of the α7 Neuronal Nicotinic Acetylcholine Receptor:In VitroandIn VivoCharacterization. Journal of Neuroscience. 25(17). 4396–4405. 372 indexed citations
20.
Piotrowski, David W.. (1997). Dynamiques et structures en langue. CNRS Éditions eBooks. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026